2025 Outlook and Expectations for Global Pharma, Biotech

On Demand

Duration: 60 Minutes

Original Date: December 12, 2024

First name

Last name

Email address

Business phone

Company

Job role

Industry

City

Country or Region

State or Province Optional

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services.

What are you interested in learning more about?

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BI's global healthcare team will discuss issues, expectations and key events anticipated in 2024 for Pharma and Biotech. Topics include regulatory change, capital allocation, growth and valuation, disease area trends and anticipated catalysts.

Speakers

John Murphy

Senior Research Analyst

Bloomberg Intelligence

Duane Wright

Senior Health Policy Analyst

Bloomberg Intelligence

Duane Wright is a Senior Health Care Analyst for the health team at Bloomberg Intelligence. Prior to joining Bloomberg he was a Vice President in the Government Affairs department for the Advanced Medical Technology Association (AdvaMed) where he was team lead on diagnostics, coverage and reimbursement issues, and led industry efforts to repeal the medical device tax in 2019. Prior to AdvaMed he was a Vice President at Finsbury Glover Hering, a multi-client consultant firm, and America’s Health Insurance Plans. Prior to his private sector work he was lead health staff for Senator Tom Carper (D-DE), and a Legislative Assistant to former Congressman Jim Davis (D-FL). Wright holds a law degree from The George Washington University, and a bachelor’s degree from the University of North Carolina at Chapel Hill.

2025 Outlook and Expectations for Global Pharma, Biotech

Speakers

Access a broad range of analysis, research, insight and actionable ideas with Bloomberg webinars.